176
Participants
Start Date
December 17, 2018
Primary Completion Date
March 31, 2021
Study Completion Date
October 5, 2021
Lenabasum 20 mg
oral capsule
Lenabasum 5 mg
oral capsule
Placebo
oral capsule
UMHAT, Stara Zagora
Hospital for Special Surgery, New York
Revmatologicky ustav, Prague
University of Pittsburgh, Division of Rheumatology, Pittsburgh
University of Pennsylvania, Philadelphia
Georgetown University, Washington D.C.
Johns Hopkins Bayview Medical Center, Baltimore
MUSC: Department of Neurology, Charleston
Mayo Clinic, Jacksonville
University of Miami, Miami
University of South Florida, Tampa
Cleveland Clinic, Cleveland
University of Michigan, Ann Arbor
Rheumatic Disease Center, Glendale
University of Minnesota, Division of Rheumatic and Autoimmune Diseases, Minneapolis
Northwestern University, Chicago
Washington University in St. Louis, St Louis
University of Kansas Medical Center, Kansas City
DelRicht Research, New Orleans
Austin Neuromuscular Center, Austin
Denver Arthritis Clinic, Denver
HonorHealth Neurology, Phoenix
Mayo Clinic, Scottsdale
UCLA Division of Rheumatology, Los Angeles
Attune Health Center, Beverly Hills
University Hospital Policlinico-Vittorio Emanuele, Catania
"University Hospital Kaspela Rheumatology Clinic", Plovdiv
"UMHAT St. Ivan Rilski", Sofia
Charite-Universitatsmedizin, Berlin
University Medical Center Goettingen, Göttingen
University of Debrecen, Debrecen
Gunma University Hospital, Gunma
Hokkaido University Hospital, Hokkaido
Yokohama City University Hospital, Kanagawa
Kyoto University Hospital, Kyoto
Tohoku University Hospital, Miyagi
Osaka University Hospital, Osaka
Keio University Hospital, Tokyo
Nippon Medical School Hospital, Tokyo
Wakayama Medical Hospital, Wakayama
KLIMED, Bialystok
Inha University Hospital, Incheon
Hanyang University Hospital, Seoul
Seoul St. Mary's Hospital, Seoul
Vall d'Hebron General Hospital, Barcelona
Hospital 12 Octubre, Madrid
Karolinska University Hospital, Rheumatology Clinic, Stockholm
King's College Hospital NHS Foundation Trust, London
University of British Columbia, Dept. of Dermatology and Skin Science, Vancouver
University Hospital Erlangen Nuremberg, Erlangen
Fondazione Policlinico Universitario A.Gemelli-IRCCS, Roma
Kliniczny Szpital Wojewodzki Nr 1. im Fryderyka Chopina Klinika Dermatologii, Rzeszów
KLIMED, Łomża
Seoul National University Hospital, Seoul
Lead Sponsor
Corbus Pharmaceuticals Inc.
INDUSTRY